414 related articles for article (PubMed ID: 23937413)
1. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
2. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
3. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
4. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
5. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H
Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381
[TBL] [Abstract][Full Text] [Related]
7. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
Yamabayashi C; Koya T; Kagamu H; Kawakami H; Kimura Y; Furukawa T; Sakagami T; Hasegawa T; Sakai Y; Matsumoto K; Nakayama M; Gelfand EW; Suzuki E; Narita I
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):170-7. PubMed ID: 22403804
[TBL] [Abstract][Full Text] [Related]
8. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
9. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
[TBL] [Abstract][Full Text] [Related]
10. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
11. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
12. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
Henderson WR; Chiang GK; Tien YT; Chi EY
Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
14. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
[TBL] [Abstract][Full Text] [Related]
15. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
16. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
[TBL] [Abstract][Full Text] [Related]
17. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse.
Eum SY; Maghni K; Hamid Q; Campbell H; Eidelman DH; Martin JG
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):25-32. PubMed ID: 12495929
[TBL] [Abstract][Full Text] [Related]
19. Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
Hsu CH; Hu CM; Lu KH; Yang SF; Tsai CH; Ko CL; Sun HL; Lue KH
Pediatr Neonatol; 2012 Aug; 53(4):235-44. PubMed ID: 22964281
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
